InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Shanahan Karin. Director active across 1 company, notably Bristol Myers Squibb Co. In total, 5 disclosures have been published. History available since 10 March 2023. The latest transaction was disclosed on 1 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations